1. Home
  2. KALV vs MOMO Comparison

KALV vs MOMO Comparison

Compare KALV & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.80

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Hello Group Inc.

MOMO

Hello Group Inc.

HOLD

Current Price

$5.90

Market Cap

926.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
MOMO
Founded
N/A
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
926.4M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
KALV
MOMO
Price
$26.80
$5.90
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.60
N/A
AVG Volume (30 Days)
5.4M
370.8K
Earning Date
07-09-2026
06-04-2026
Dividend Yield
N/A
4.61%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
N/A
Revenue Next Year
$59.23
$3.68
P/E Ratio
N/A
$10.60
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$5.69
52 Week High
$26.85
$9.22

Technical Indicators

Market Signals
Indicator
KALV
MOMO
Relative Strength Index (RSI) 74.68 38.90
Support Level $14.25 $5.69
Resistance Level $26.85 $6.47
Average True Range (ATR) 0.07 0.15
MACD -0.22 -0.04
Stochastic Oscillator 71.05 15.25

Price Performance

Historical Comparison
KALV
MOMO

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About MOMO Hello Group Inc.

Hello Group Inc is a foremost player in Asia's online social networking space. Through Momo, Tantan and other properties within its product portfolio, It enable users to discover new relationships, expand their social connections and build meaningful interactions. Momo is a mobile application that connects people and facilitates social interactions based on location, interests and a variety of online recreational activities. Tantan, which it added to its family of applications through acquisition. Tantan is designed to help its users find and establish romantic connections as well as meet interesting people. The Group determined that it operated in three operating segments namely Momo, Tantan and QOOL. The majority of revenue comes from Chinese mainland as compare to Overseas.

Share on Social Networks: